Ivabradine in patients with heart failure: a systematic literature review | 2023 | Journal of market access & health policy |
Comparative Efficacy of Different Drugs for the Treatment of Dilated Cardiomyopathy: A Systematic Review and Network Meta-analysis | 2023 | Drugs in R&D |
Meta-Analysis on Drug and Device Therapy of New York Heart Association Functional Class IV Heart Failure With Reduced Ejection Fraction | 2023 | The American journal of cardiology |
The effect of ivabradine therapy on dilated cardiomyopathy patients with congestive heart failure: a systematic review and meta-analysis | 2023 | Frontiers in cardiovascular medicine |
Ivabradine and atrial fibrillation: a meta-analysis of randomized controlled trials. | 2022 | Journal of Cardiovascular Pharmacology |
A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction | 2022 | JACC. Heart failure |
Network meta-analysis of medical therapy efficacy in more than 90,000 patients with heart failure and reduced ejection fraction | 2022 | Journal of internal medicine |
Efficacy of new medical therapies in patients with heart failure, reduced ejection fraction, and chronic kidney disease already receiving neurohormonal inhibitors: a network meta-analysis | 2022 | European heart journal. Cardiovascular pharmacotherapy |
Comparative Efficacy of Medical Treatments for Chronic Heart Failure: A Network Meta-Analysis | 2022 | Frontiers in cardiovascular medicine |
Effectiveness and safety of ivabradine in the treatment of acute myocardial infarction: a systematic review and meta-analysis. | 2021 | Annals of Palliative Medicine |
Pharmacotherapies in heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials. | 2021 | Cureus |
Pharmacotherapy for heart failure with reduced ejection fraction and health-related quality of life: a systematic review and meta-analysis. | 2021 | European Journal of Heart Failure |
Impact of ivabradine on the cardiac function of chronic heart failure reduced ejection fraction: meta-analysis of randomized controlled trials. | 2021 | Clinical Cardiology |
Effect of ivabradine on exercise capacity in individuals with heart failure with preserved ejection fraction. | 2021 | Heart Failure Reviews |
Effect of ivabradine in heart failure: a meta-analysis of heart failure patients with reduced versus preserved ejection fraction | 2021 | Canadian journal of physiology and pharmacology |
Effect of ivabradine on major adverse cardiovascular events and mortality in critically ill patients: a systematic review and meta-analyses of randomised controlled trials with trial sequential analyses. | 2020 | British Journal of Anaesthesia |
New pharmacological treatments for heart failure with reduced ejection fraction (HFrEF): A Bayesian network meta-analysis | 2020 | Medicine |
Effects of Ivabradine on Cardiac Remodeling in Patients With Stable Symptomatic Heart Failure: A Systematic Review and Meta-analysis | 2020 | Clinical therapeutics |
Effect of Ivabradine on Left Ventricular Diastolic Function, Exercise Tolerance and Quality of Life in Patients With Heart Failure: A Systemic Review and Meta-Analysis of Randomized Controlled Trials | 2020 | Cardiology research |
Ivabradine Improves Cardiac Function and Increases Exercise Capacity in Patients with Chronic Heart Failure | 2019 | International heart journal |
The effect of ivabradine therapy on heart failure patients with reduced ejection fraction: a systematic review and meta-analysis. | 2018 | International Journal of Clinical Pharmacy |
The effect of ivabradine therapy on heart failure patients with reduced ejection fraction: a systematic review and meta-analysis | 2018 | International Journal of Clinical Pharmacy |
Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis | 2018 | European journal of heart failure |